Target intelligence / Profile preview

Endoplasmic reticulum P5A-ATPase (ATP13A1)

Target
ATP13A1
Molecular classification
P-type ATPase, P5A-ATPase, Enzyme, Transporter, Membrane protein dislocase
01

Overview

Endoplasmic reticulum P5A-ATPase (ATP13A1) is an evolutionarily conserved P-type ATPase enzyme localized in the endoplasmic reticulum (ER) membrane[2][1][3][6]. It functions as a protein dislocase, removing mislocalized mitochondrial tail-anchored proteins and substrates with misoriented N-terminal transmembrane domains from the ER, thus maintaining proteome quality and correct protein topogenesis[1][2][6][4]. ATP13A1 also contributes to cellular manganese ion homeostasis by mediating manganese transport into the ER, affecting various manganese-dependent processes[3][5]. Dysfunction or absence of ATP13A1 impairs protein folding, increases ER stress, disrupts manganese homeostasis, and may predispose to neurodegenerative diseases[5][6][3]. It is part of the P5A subfamily of P-type ATPases and is not currently known to be the direct target of any approved therapeutics or drugs.

Other names
ATP13AKIAA1825FLJ31858CGI-152endoplasmic reticulum transmembrane helix translocasemanganese-transporting ATPase 13A1probable cation-transporting ATPase 13A1
02

Mechanism of action

ATP-driven transport (of cations, especially manganese) and protein dislocation/removal based on substrate recognition; maintains protein and ion homeostasis in the ER

03

Biological functions

Protein quality control in the endoplasmic reticulumRemoval of mislocalized mitochondrial tail-anchored proteins from the ERProtein dislocation from ER membraneFacilitating correct topogenesis (membrane targeting/orientation) of N-terminal transmembrane and signal sequencesCellular manganese ion homeostasis
04

Disease associations

Neurodegenerative disease, including Parkinson’s diseaseKufor–Rakeb syndromeroles in manganese-dependent neurological disorderspossible association with hypogonadotropic hypogonadism
05

Safety considerations

Loss or dysfunction leads to accumulation of mislocalized or misoriented proteinsER stressimpaired manganese-dependent enzymatic functionpotential to affect proteome fidelity or contribute to neurological dysfunction

Beyond the preview

Go deeper on Endoplasmic reticulum P5A-ATPase (ATP13A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endoplasmic reticulum P5A-ATPase (ATP13A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call